Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon.

doi:10.11604/pamj.2025.52.122.46773

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon.

The Pan African medical journal - 1 Jan 2025

Djoda Bello, Fru-Cho Jerome, Njukeng Patrick Achiangia, Semengue Ezechiel Ngoufack Jagni, Fokou Patrick Valere Tsouh, Molimbou Evariste, Etame Naomi-Karell, Wouambo Rodrigue Kamga, Wilhelm Bauer, Dächert Christopher, Megaptche Alain Nantchouang, Muenchhoff Maximilian, Wade Abel, Van Cleaf Stefanie, Eberle Josef, Fokounang Charles, Fokam Joseph, Keppler Oliver Till, Bosnjak Oliver

Abstract excerpt

Introduction: despite the success of antiretroviral therapy (ART), the emergence of HIV drug resistance (HIVDR) remains a major threat in sub-Saharan Africa, where therapeutic options remain limited. With the goal of supporting ART response, we sought to monitor viral load (VL) response and acquired HIVDR emergence among patients initiating ART in the Cameroonian setting. Methods: a facility-based cohort study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cameroon

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Kaplan-Meier Estimate

Share to Rural Population

Share to Urban Population

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 41727537
DOI: 10.11604/pamj.2025.52.122.46773
PMCID: PMC12920547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon.PMID 41727537Read ↗

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity Read ↗

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.Semantic proximity Read ↗

Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.Semantic proximity Read ↗

Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in CameroonSemantic proximity Read ↗

Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.Semantic proximity Read ↗

Trends in demographic and clinical characteristics of patients enrolled in HIV care and subsequent Antiretroviral Therapy initiation in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) Adult Cohort 2004-2018Semantic proximity Read ↗

Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.Semantic proximity Read ↗

Dolutegravir-Based Therapy is Essential in Achieving HIV Epidemic Control in Low- and Middle-Income Countries: Real-Life Evidence from a Large Clinical Cohort in CameroonSemantic proximity Read ↗

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.Semantic proximity Read ↗

Nationwide patterns of HIV drug resistance and high viral load in Sub-Saharan African countries.Semantic proximity Read ↗

High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.Semantic proximity Read ↗

Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.